Our data indicated that combination of the clinical risk scores (TNM stage, histologic type, and tumor diameter), TIMP-2 or MMP-9 or TIMP-2 plus MMP-9 expression predicted prognosis of CRC. This evidence concerns the gene TIMP2 and neoplasm.